According to Renub Research forecast the global Spinal Muscular Atrophy Market to grow at a CAGR of 14% in the coming years. This high growth rate is primarily due to good reimbursement options in western countries, declining drug prices and projected launch of new drugs. One of the major growth drivers witnessing the growth of spinal muscular atrophy market is growing awareness of diagnosis and treatment of spinal muscular atrophy during the forecast period.

Spinal fusion is multi Billion dollar market with huge future potential. In 2014 Spinal fusion market was more than US$ 20 Billion. Germany, United States and China are the top three markets (not in the same chronological order) worldwide. In 2014, Spinal fusion procedure volume has crossed over 1 Million. India had more spinal fusion cases than France in 2014.Global phenomenon of an aging society and the associated increasing incidences of degenerative spinal conditions and 3D imagine technology will drive this market globally. Spinal fusion surgery to become one of the most frequently performed surgeries worldwide.

This report is a business analysis that has the primary purpose of examining trends and highlighting current and future potential in the market for spinal surgical devices. Detailed analysis of the competitive environment and technological development is provided in the report.

The report includes current and new technologies, market projections and the market shares of key market players. Market drivers, trends and potential regional market opportunities for Spinal Surgical Devices are also identified in this report. This is an update from the previous version of this report and the analysis of clinical trials, presence of key players in respective spinal surgical segments and key developments are some of the additions.

Global Pharmaceutical Drug Delivery Market is projected to reach USD 1,694.7 billion by 2023 from USD 1,244.4 billion in 2018, at a CAGR of 6.4% during the forecast period. Growth in this market is mainly driven by the rising prevalence of chronic diseases, growth in the biologics market, and technological advancements and new product launches. On the other hand, the risk of needlestick injuries and the increasing pricing pressure are expected to challenge market growth in the coming years.

Global HTPB Market valued approximately USD 120.0 Million in 2016 is anticipated to grow with a healthy growth rate of more than 10.50% over the forecast period 2017-2025. A key factor which gives growth to the HTPB market are growing demand for missiles and rockets requiring technologically efficient HTPB-based rocket fuel and rising investment in space technologies are major drivers of the global HTPB market during the forecast period North and America is expected to be the largest market for HTPB during the forecast period, due to the increased usage of HTPB in both aerospace & defense and construction & civil engineering industries in the region.

According to a report published by Renub Research, Global Epilepsy Drugs Market is anticipated to be more than USD 9 Billion opportunity for pharmaceutical companies by 2025. In addition, owing to the approvals of new drugs for epilepsy further expected to boost the growth of epilepsy drugs market over the forecast period. On the other hand, recent patent expiration of major brands offers massive opportunity for the generic drugs to come up in the market.